The UPF debate just got more complicated. A new expert panel is pushing federal regulators to stop treating all ultra-processed foods as a single villain. Some UPFs, they argue, belong in the “healthy” column, and the FDA’s current criteria should reflect that.
TLDR
- Expert panel calls for modified FDA ‘healthy’ criteria for beneficial UPFs.
- Not all ultra-processed foods carry the same health risk, research shows.
- The split could reshape labeling, policy, and product positioning fast.
- Manufacturers of fortified or functional UPFs have the most to gain.
- Inaction by FDA risks painting reformulated products with the same brush.
Ultra-Processed Food Regulation Needs a Sharper Line
Reporting from FoodNavigator-USA, a newly convened expert panel argues that blanket UPF restrictions are too blunt. Specifically, they recommend modifying the FDA’s existing “healthy” nutrient criteria to carve out a protected category for beneficial ultra-processed foods. Think: fortified cereals, meal replacements, and clinically recommended nutritional products.
The distinction matters enormously for manufacturers. Products that meet reformulation benchmarks but still qualify as UPFs under NOVA classification could face policy headwinds they don’t scientifically deserve.
Where the FDA’s ‘Healthy’ Criteria Falls Short
The FDA updated its “healthy” claim definition in 2024. However, that update did not address NOVA-based processing classifications directly. The gap leaves a growing number of functional, fortified, and diet-quality products in regulatory limbo.
Significant. The panel’s recommendation would effectively create a tiered framework. Harmful UPFs, high in sodium, added sugars, and saturated fat, would remain targets. Beneficial UPFs, those doctors actively recommend, would earn explicit exemption.
For food operators, this is a signal worth tracking closely. Retailers building clean-label and better-for-you assortments need clarity on which UPFs can carry credible health positioning. Suppliers reformulating toward functional benefits need regulatory footing to justify investment.
The panel’s framework, if adopted, would reward science-backed product development. It would also make visible which manufacturers have done the work, and which have not.
Source: FoodNavigator-USA. https://www.foodnavigator-usa.com